RxDoctor Payments Data

Lyndsey Slape

Family · Miami, FLNPI 1245836592

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 277 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,638 and has fallen 67.5% since, to $857 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,397in general payments, 2019–2025

Across 277 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • E.r. Squibb & Sons, L.L.C.$619
  • Dermavant Sciences, Inc.$424
  • Lilly USA, LLC$381
  • Amgen$363
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$6,05495%
  • Education$3435%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,397 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Medicare billing

Part B allowed, 2024
$62,750
Medicare patients
214
Services billed
1,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab16$67,207
Tacrolimus55$7,309
Pimecrolimus14$5,643
Mycophenolate Mofetil24$4,855
Clobetasol Propionate92$3,924
Cyclosporine ModifiedCyclosporine, Modified12$2,154
Doxycycline Hyclate32$964
Betamethasone Dipropionate12$894
Minoxidil49$758
Dutasteride29$758
Triamcinolone Acetonide50$603
Gabapentin41$445
Hydrocortisone66$421
ValacyclovirValacyclovir Hcl15$330
Minocycline Hcl12$246

Paid to pharmacies, not to this prescriber.

Other family in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →